China says uptick in respiratory illnesses is caused by flu and known pathogens, not a novel virus; Xenon Pharmaceuticals’ experimental major depressive disorder drug fails in Phase 2 trial; AbbVie, Genmab announce the FDA granted breakthrough therapy designation to their epcoritamab treatment.
Five things for pharma marketers to know: Monday, November 27, 2023
Lawmakers urge SEC to investigate Elon Musk’s comments on Neuralink; Syncona to buy Freeline Therapeutics; Sen. Bernie Sanders calls on Big Pharma CEOs to testify at January hearing on high drug prices.
Five things for pharma marketers to know: Wednesday, November 22, 2023
Novo Nordisk warns weight loss drug shortages will persist throughout 2024; Flagship launches first U.K.-based startup; Cathie Wood’s big bet on Recursion Pharmaceuticals.
Five things for pharma marketers to know: Tuesday, November 21, 2023
Bayer halts heart drug following negative drug-trial result; Hope springs eternal for Alzheimer’s disease vaccines; Snoop Dogg gives up smoke fireplaces, not cannabis.
Five things for pharma marketers to know: Monday, November 20, 2023
Walgreens to close most stores on Thanksgiving for first time; Eli Lilly to open $2.5B factory in Germany to meet GLP-1 demand; Rite Aid sues DOJ in bid to stop opioid lawsuit.
Five things for pharma marketers to know: Friday, November 17, 2023
Unpacking the U.K.’s approval of the first CRISPR treatment for diseases; Pfizer CEO Albert Bourla attends a dinner with Chinese President Xi Jinping; FDA’s Janet Woodcock plans to retire next year.
Five things for pharma marketers to know: Thursday, November 16, 2023
Sanofi explores consumer health spinoff; FTC warns trade groups, influencers about social media posts promoting aspartame; Graphite Bio agrees to merge with Lenz Therapeutics.
Five things for pharma marketers to know: Wednesday, November 15, 2023
Social media companies must face youth addiction lawsuits; President Biden, Premier Xi Jinping set to announce deal to crack down on the manufacture and export of fentanyl; UnitedHealth Group used algorithm to cut off payments to Medicare patients who needed rehab stays
Five things for pharma marketers to know: Tuesday, November 14, 2023
VectorY secures $138 million in Series A to develop ALS treatment; Eli Lilly’s experimental drug lowers a heart disease risk factor in just one dose; House Republicans seeking to cut 95% of Trump-era HIV initiative.
Five things for pharma marketers to know: Monday, November 13, 2023
Novo Nordisk to invest more than $6 billion to boost production capacity; The FDA approves first chikungunya virus vaccine; Exemption rates for childhood vaccines on the rise.